Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2007-10-02 | Forward | 2:1 |
| 2006-08-14 | Forward | 2:1 |
Simulations Plus, Inc. develops AI-driven drug discovery and development software for modeling, simulation, and prediction of molecular properties, serving pharma, biotech, and related industries worldwide.

GastroPlus® X is a leading PBPK modeling software by Simulations Plus, used in pharma and biotech to predict drug ADME, optimize formulations, and reduce drug development time and costs.
| Icon | PRODUCT | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|---|
![]() | License and Maintenance | $9.01M | $8.88M ▼ | $14.63M ▲ | $12.61M ▼ |
![]() | Service | $8.45M | $9.54M ▲ | $9.66M ▲ | $9.28M ▼ |
| Map | REGION | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 |
|---|---|---|---|---|---|
![]() | North And South America | $12.58M | $13.45M ▲ | $16.58M ▲ | $16.06M ▼ |
![]() | Europe | $2.97M | $3.13M ▲ | $5.96M ▲ | $3.58M ▼ |
![]() | Asia | $1.92M | $1.84M ▼ | $1.76M ▼ | $2.24M ▲ |
Overall rating: A-
| PEER | PRICE | |
|---|---|---|
AGL | $92.54 | COMPARE |
ANRO | $35.13 | COMPARE |
SOPH | $8.14 | COMPARE |
NRC | $21.85 | COMPARE |
CLLS | $3.40 | COMPARE |
ACIU | $2.65 | COMPARE |
OPRX | $7.95 | COMPARE |
NAKA | $7.44 | COMPARE |